openPR Logo
Press release

Convincing new Norwegian heart sensor

12-07-2021 11:49 AM CET | Health & Medicine

Press release from: Startup Campus Germany UG

After more than 4 years of development, ECG247 is now medically certified and available to everyone in pharmacie

After more than 4 years of development, ECG247 is now medically certified and available to everyone in pharmacie

The innovative ECG247 heart sensor, developed and manufactured in Norway, proves to be better in a direct comparison than the cardiac arrhythmia detection devices previously used by most hospitals and cardiac specialists worldwide. This is the finding of a new study published in the Journal of Healthcare Engineering. "ECG247 makes it easier to detect severe cardiac arrhythmias before they cause symptoms," says Tord Ytterdahl, developer and CEO of Appsens AS and ECG247.
The ECG247 heart sensor was developed in collaboration with researchers at Sorlandet Hospital and the University of Agder. The system consists of a small, reusable sensor that is attached over the sternum with a special patch. The sensor communicates with an app on the smartphone and uses artificial intelligence to analyze the heart rhythm in real time. The results can be easily shared with a primary care physician or cardiologist. ECG247 is already used by many GPs and cardiologists in Norway.
Edvard L. Sandberg, a physician and doctoral student at Sorlandet Hospital, in collaboration with researchers at Oslo University Hospital and St. Olavs Hospital, compared the ECG247 heart sensor with standard hospital equipment for detecting cardiac arrhythmias (known as a Holter examination or long-term ECG). In the study, both systems were applied to 150 patients for several days. The ECG247 sensor detected arrhythmias as well as Holter technology, but had far fewer erroneous test results. In addition, the study showed that ECG247 was easier and more convenient to use than a conventional Holter device.
Atrial fibrillation is the most common cardiac arrhythmia and is associated with an increased risk of stroke, heart failure, dementia and premature death, among others. However, if the condition is caught early enough, there are good preventive medications. Ytterdahl hopes the study can contribute to wider international adoption of ECG247. In entering the German market, the european accelerator Startup Campus Germany is providing support. Startup Campus works in particular with startups in the fields of digital health and Industry 4.0. The aim is to provide professional preparation before entering the German market and comprehensive support during the process in order to build long-term partnerships. Through the cooperation with numerous startups, it became apparent that reaching out to a global market is challenging. Startup Campus Germany builds bridges between international ecosystems and supports the internationalization of startups. This includes dealing with local regulations, cultural differences and global precautions, among other things.
"After more than 4 years of development, we are proud that ECG247 is now medically certified and available to everyone in pharmacies. The study confirms that ECG247 is reliable, accurate and easy to use." Ytterdahl hopes early detection of cardiac arrhythmias with ECG247 will help prevent serious complications such as stroke. "Many people who experience palpitations from time to time can now easily test themselves," he says.
For more information about ECG247, visit 
Link to the study mentioned: "Diagnostic Accuracy and Usability of the ECG247 Smart Heart Sensor Compared to Conventional Holter Technology."

Startup Campus Germany UG

Rosenheimer Straße 143/C 81671 München

Startup Campus Germany is an european accelerator and helps Startups entering the German market.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Convincing new Norwegian heart sensor here

News-ID: 2487804 • Views: 629

More Releases for ECG

ECG Cable and ECG Lead Wires Market
Allied Market Research (USA, Oregon, Portland) Published Latest Report titled, ‘ECG Cable and ECG Lead Wires Market: Global Opportunity Analysis and Industry Forecast 2020-2027’. This market research study determines the increase in changes and the aspects which are likely to have an impact on the growth of the ECG Cable and ECG Lead Wires Market. Increased demand for the technologies is also one of the factors, which are likely to boost
ECG Cable and ECG Lead Wires Market Opportunity Analysis, 2018-2026
Electrocardiograph machines are used to measure the electrical activity of a patient’s heart. The electrical activity of the heart is recorded with the help of 12-lead ECGs and 10 electrodes placed on patient’s limbs and surface of the chest. Furthermore, ECG applies to monitor the patient’s emergency situation to obtain quick results of heart’s size, position of heart chambers, the rate of the heart, rhythm, and any damage to heart
Diagnostic Electrocardiograph (ECG) Market Report 2018: Segmentation by Product …
Global Diagnostic Electrocardiograph (ECG) market research report provides company profile for Fukuda Denshi, Welch Allyn, Mortara Instrument, NIHON KOHDEN, GE Healthcare, Philips, BioTelemetry, Suzuken and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The
ECG Cables and ECG Lead Wires Market succouring demand 2025
Global ECG Cables and ECG Lead Wires Market: Snapshot ECG cables and lead wires are a key equipment needed for electrocardiography, a monitoring technique used in several cardiac diseases. The global ECG cables and lead wires market has thus been driven primarily by the rising prevalence of cardiovascular conditions among the modern urban demographic and the growth of the geriatric demographic, which has led to rising demand for cardiac monitoring equipment.
Global ECG cables and ECG leadwires Sales Market industry Report 2017
A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is titled “Global ECG cables and ECG leadwires Sales Market” which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview. The report anticipates that the sector for Medical Equipments would rise at a positive CAGR during the period 2017-2022.
ECG Equipment & Management System Market Analysis By Type (Holter Monitors, Rest …
Introduction Electrocardiogram (ECG) devices record and test the cardio activity electrically. The electrical impulse that is generated by cardiac tissues is recorded by ECG by polarization and depolarization mechanism. ECG devices are of excessive help to physicians and cardiologist for proper and early detection of cardiac disorders and diagnosis like inflammation of heart, abnormal heart rhythm, congenital heart defect, poor supply of blood to the arteries and many more. ECG stress